FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 1852755 · Received October 4, 2010

Report

Report Number
2124215-2010-14759
Event Type
Injury
Date Received
October 4, 2010
Date of Event
July 15, 2010
Report Date
July 15, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THIS LEAD REMAINS IN SERVICE. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT EXPERIENCED CARDIAC TAMPONADE THE NIGHT AFTER IMPLANT. THE FIELD REPRESENTATIVE NOTED THAT WHEN DOING THE POST IMPLANT CHECK THE RIGHT VENTRICULAR (RV) LEAD IMPEDANCE MEASUREMENTS POST RV LEAD REPOSITIONING WENT FROM 730 OHMS TO 490 OHMS. TO DATE, NO FURTHER ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4470

Patients

Seq Age Sex Outcome Treatment
1 75 YR Life Threatening| R 4469| 4470| S603